Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.
Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.
复制标题
DOI:
10.1086/315739
复制
发表时间:
2000-08
期刊:
影响因子:
--
通讯作者:
Ilana Fogelman;V. Davey;Hans D. Ochs-Hans D.-Ochs-2254298500;Michael Elashoff;M. B. Feinberg;J. Mican;Jay P. Siegel-Jay P.-Siegel-2254001668;Michael Sneller;H. Lane
中科院分区:
文献类型:
--
作者:
Ilana Fogelman;V. Davey;Hans D. Ochs-Hans D.-Ochs-2254298500;Michael Elashoff;M. B. Feinberg;J. Mican;Jay P. Siegel-Jay P.-Siegel-2254001668;Michael Sneller;H. Lane
Bacteriophage phiX174 immunization was used to measure CD4(+) T cell function in vivo in human immunodeficiency virus (HIV)-infected patients across all disease stages. Function was evaluated by measuring the ability of T cells to provide help to B cells in antibody production, amplification, and isotype switching. A total of 33 patients and 10 controls received 3 bacteriophage phiX174 immunizations 6 weeks apart. The patients' responses regarding bacteriophage-specific total antibody titers and IgG titers were quantitatively and qualitatively inferior to the controls' responses. Overall, 7 of 33 patients had normal T cell function. Baseline CD4 counts provided the strongest correlation with total antibody and IgG titers. HIV RNA had a weaker association with responses but had some predictive power among patients with a CD4 count >200 cells/microL. Bacteriophage phiX174 immunization seems to be a useful tool for measuring immune function in vivo, which suggests that most HIV-infected patients may have abnormal CD4(+) T cell function despite adequate antiretroviral treatment.